the role of venetoclax in previously treated waldenström’s macroglobulinemia
Published 1 year ago • 158 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
2:06
the role of venetoclax in r/r mcl & options for patients who progress on venetoclax
-
1:36
the synergetic mechanism of pivekimab sunirine and venetoclax and its potential for treating aml
-
2:08
the role of venetoclax in the treatment of cll
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
-
2:16
venetoclax-based salvage therapy in patients with r/r aml previously treated with targeted agents
-
12:46
fixed duration treatment strategies in cll
-
3:03
outcomes following venetoclax monotherapy in patients with r/r wm in the real-world setting
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
2:45
the addition of venetoclax to hmas for the treatment of cmml: a retrospective psm analysis
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
0:51
phase i study of copanlisib plus venetoclax in r/r dlbcl
-
2:03
the use of venetoclax in r/r al amyloidosis
-
1:55
the evolving role of venetoclax in cll
-
0:43
elm-2: qol and orr outcomes of odronextamab treatment for r/r fl
-
1:17
novel treatment approaches being explored in amyloidosis: immunotherapeutic agents & venetoclax
-
1:09
dec-c plus venetoclax in hr-mds and cmml: an analysis using different response criteria
-
1:52
evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in richter's transformation
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
2:09
overview of the cll13 trial: replacing chemotherapy with venetoclax-containing regimens
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
2:05
results from the phase i sal-relax trial: venetoclax plus cytarabine and mitoxantrone in r/r aml